{'fraction_non_alphanumeric': 0.055229142185663924, 'fraction_numerical': 0.02937720329024677, 'mean_word_length': 4.958041958041958, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Spinal alpha-adrenoceptor and dynorphin involvement in the depressor effect of clonidine].

Intrathecal injection (ith) of clonidine (1 μg) in rats caused a decrease in the mean blood pressure (-52±12mm Hg, ±SD) and heart rate (-99±24 beats/min) which were partly antagonized by ith α-adrenoceptor blocker phentolamine (30μg), or the selective α1 or α2-adrenoceptor blocker prazosin or yohimdine (30 μg, respectively). The effects of clonidine was also blocked by opiate antagonist naloxone (10 mg/kg, iv) or by pretreatment with dynorphin antiserum (10μl,ith). Naloxone (0.5 mg/kg, iv) or pretreatment with control serum (10 μl, ith) failed to reduce the effects of clonidine. The results suggest that an activation of α1 and α2-receptors and the release of dynorphin in spinal cord are important for mediating the depressor effect of ith clonidine.